Identification of androgen-responsive genes that are alternatively regulated in andirogen-dependent and androgen-independent rat prostate tumors

被引:5
作者
Pfundt, R
Smit, F
Jansen, C
Aalders, T
Straatman, H
van der Vliet, W
Isaacs, J
van Kessel, AG
Schalken, J
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet 417, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Ctr Med, Dept Urol, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Ctr Med, Dept Epidemiol & Biostat, Nijmegen, Netherlands
[4] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
关键词
D O I
10.1002/gcc.20184
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The vast majority of androgen-dependent prostate tumors progress coward incurable, androgen-independent tumors. The identification of androgen-responsive genes, which are still actively transcribed in the tumors of patients who have undergone androgen ablation, may shed light on the molecular mechanisms underlying this phenomenon. To address this question, we chose the Dunning R3327 rat model system, in which the progression from androgen-dependent to -independent tumors is represented by several transplantable prostate-derived tumors. Gene expression profiles were analyzed in normal rat prostates and in the prostates of rats 14 days after castration by use of microarrays containing approximately 5,000 oligonucleotides, together representing more than 4,800 known rat genes. These expression profiles were compared with similarly obtained expression profiles of androgen-dependent and androgen-independent rat prostate tumors. By doing so, a series of known and novel prostate cancer-associated androgen-responsive genes was identified. Within this series, we were able to identify several clusters of genes that are differentially regulated in the various prostate tumors. These genes may serve as (i) novel prognostic identifiers and (ii) novel therapeutic targets. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:273 / 283
页数:11
相关论文
共 46 条
[1]   A direct β-catenin-independent interaction between androgen receptor and T cell factor 4 [J].
Amir, AL ;
Barua, M ;
McKnight, NC ;
Cheng, ST ;
Yuan, X ;
Balk, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (33) :30828-30834
[2]  
AUFFRAY C, 1980, EUR J BIOCHEM, V107, P306
[3]   TGF-β/Smad signaling in prostate cancer [J].
Bello-DeOcampo, D ;
Tindall, DJ .
CURRENT DRUG TARGETS, 2003, 4 (03) :197-207
[4]   Activation of β-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation [J].
Bierie, B ;
Nozawa, M ;
Renou, JP ;
Shillingford, JM ;
Morgan, F ;
Oka, T ;
Taketo, MM ;
Cardiff, RD ;
Miyoshi, K ;
Wagner, KU ;
Robinson, GW ;
Hennighausen, L .
ONCOGENE, 2003, 22 (25) :3875-3887
[5]   TCF: Lady justice casting the final verdict on the outcome of Wnt signalling [J].
Brantjes, H ;
Barker, N ;
van Es, J ;
Clevers, H .
BIOLOGICAL CHEMISTRY, 2002, 383 (02) :255-261
[6]   Bone morphogenetic protein signaling in prostate cancer cell lines [J].
Brubaker, KD ;
Corey, E ;
Brown, LG ;
Vessella, RL .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (01) :151-160
[7]   Rat ventral prostate microsomal biotransformation of ethanol to acetaldehyde and 1-hydroxyethyl radicals:: Its potential contribution to prostate tumor promotion [J].
Castro, GD ;
de Layño, AMAD ;
Costantini, MH ;
Castro, JA .
TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS, 2002, 22 (05) :335-341
[8]   Stromal factors involved in prostate carcinoma metastasis to bone [J].
Cooper, CR ;
Chay, CH ;
Gendernalik, JD ;
Lee, HL ;
Bhatia, J ;
Taichman, RS ;
McCauley, LK ;
Keller, ET ;
Pienta, KJ .
CANCER, 2003, 97 (03) :739-747
[9]  
Cronauer MV, 2003, INT J ONCOL, V23, P1095
[10]   The role of androgens and the androgen receptor in prostate cancer [J].
Debes, JD ;
Tindall, DJ .
CANCER LETTERS, 2002, 187 (1-2) :1-7